Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)

EGX:MPCI Revenue

In the fiscal year ending June 30, 2026, Memphis Pharmaceuticals & Chemical Industries had annual revenue of 1.71B EGP with 13.14% growth. Memphis Pharmaceuticals & Chemical Industries had revenue of 375.20M in the quarter ending June 30, 2026, a decrease of -8.60%. That makes Memphis Pharmaceuticals & Chemical Industries the 30,972nd largest company in the world by revenue and 109th in Egypt.

• Revenue: 1.71B
• Revenue Growth: +13.14%
• P/S Ratio: 4.06
• Revenue / Employee: 11.85M
• Employees: 144
• Market Cap: 6.92B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	1.71B	198.12M	13.14%
Jun 30, 2025	1.51B	635.90M	72.93%
Jun 30, 2024	871.91M	208.07M	31.34%
Jun 30, 2023	663.83M	112.57M	20.42%
Jun 30, 2022	551.26M	33.15M	6.40%

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error